Clinical Trial

Cardiovascular Research in EMbarazo and MAternity (EMMA). Study on Heart Rate Variability and Hemodynamic Adaptations During Pregnancy and Postpartum.

Study acronym: EMMA
Recruiting
View on ClinicalTrials.gov →
Summary
Heart rate variability (HRV) provides a non-invasive assessment of autonomic control of the nervous system over the heart. During pregnancy, the cardiovascular system adapts significantly, affecting HRV and hemodynamics. Studying the relationship between HRV and hemodynamic changes is critical to understanding and monitoring cardiovascular health during pregnancy and postpartum, and predicting potential complications.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-01-26; most recent amendment 2026-02-12.
Status change: Active, Not Recruiting → Recruiting 2026-02-11
Trial Details
NCT Number NCT07376616
Lead Sponsor Fundacin Biomedica Galicia Sur
Conditions Pregnancy Related, Heart Rate Variation (HRV), Hemodynamics
Enrollment 242 participants
Start Date 2025-05-19
Primary Completion 2027-12-15 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-02-17